Mehmet Kanbay

19.2k total citations · 5 hit papers
433 papers, 12.6k citations indexed

About

Mehmet Kanbay is a scholar working on Nephrology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mehmet Kanbay has authored 433 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Nephrology, 110 papers in Surgery and 92 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mehmet Kanbay's work include Dialysis and Renal Disease Management (68 papers), Gout, Hyperuricemia, Uric Acid (53 papers) and Chronic Kidney Disease and Diabetes (47 papers). Mehmet Kanbay is often cited by papers focused on Dialysis and Renal Disease Management (68 papers), Gout, Hyperuricemia, Uric Acid (53 papers) and Chronic Kidney Disease and Diabetes (47 papers). Mehmet Kanbay collaborates with scholars based in Türkiye, Romania and United States. Mehmet Kanbay's co-authors include Adrian Covic, Barış Afşar, Richard J. Johnson, Alberto Ortíz, Yalçın Solak, Miguel A. Lanaspa, David Goldsmith, Dimitrie Siriopol, Adrian Covic and Sidar Çöpür and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Mehmet Kanbay

410 papers receiving 12.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress

2012 572 citations Miguel A. Lanaspa, Laura Gabriela Sánchez‐Lozada et al. profile →
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

2014 310 citations Alberto Ortíz, Mehmet Kanbay et al. profile →
The systemic nature of CKD

2017 300 citations Carmine Zoccali, Alberto Ortíz et al. profile →
Uric acid in metabolic syndrome: From an innocent bystander to a central player

2015 293 citations Mehmet Kanbay, Carlos A. Roncal-Jiménez et al. European Journal of Internal Medicine profile →
Uric acid in metabolic syndrome: Does uric acid have a definitive role?

2022 165 citations Sidar Çöpür, Mehmet Kanbay et al. European Journal of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mehmet Kanbay Türkiye	58	5.7k	2.9k	2.0k	2.0k	1.9k	433	12.6k
Kosaku Nitta Japan	46	7.6k 1.3×	2.3k 0.8×	3.0k 1.4×	2.1k 1.1×	1.4k 0.8×	598	14.8k
Kunihiro Yamagata Japan	43	5.3k 0.9×	1.9k 0.7×	2.6k 1.3×	2.0k 1.0×	1.8k 0.9×	316	12.5k
Michel Chonchol United States	62	5.8k 1.0×	2.2k 0.8×	2.8k 1.4×	1.8k 0.9×	2.5k 1.3×	320	14.2k
Akira Hishida Japan	48	4.7k 0.8×	2.9k 1.0×	2.7k 1.3×	2.2k 1.1×	1.5k 0.8×	298	13.6k
Shin‐Wook Kang South Korea	55	6.1k 1.1×	1.7k 0.6×	1.4k 0.7×	2.2k 1.1×	1.3k 0.7×	530	12.4k
Seiichi Matsuo Japan	60	6.9k 1.2×	2.9k 1.0×	3.2k 1.6×	3.1k 1.6×	1.9k 1.0×	321	17.7k
Kunitoshi Iseki Japan	58	8.4k 1.5×	2.2k 0.8×	2.9k 1.4×	933 0.5×	1.9k 1.0×	321	13.1k
Barry I. Freedman United States	65	6.2k 1.1×	1.8k 0.6×	2.6k 1.3×	3.3k 1.6×	1.7k 0.9×	420	16.3k
John H. Eckfeldt United States	55	3.9k 0.7×	2.5k 0.9×	2.5k 1.2×	1.7k 0.9×	1.8k 0.9×	194	14.9k
Yoshinari Yasuda Japan	40	4.1k 0.7×	1.6k 0.6×	2.3k 1.1×	1.8k 0.9×	1.1k 0.6×	152	10.6k

Countries citing papers authored by Mehmet Kanbay

Since Specialization

Citations

This map shows the geographic impact of Mehmet Kanbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehmet Kanbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehmet Kanbay more than expected).

Fields of papers citing papers by Mehmet Kanbay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehmet Kanbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehmet Kanbay. The network helps show where Mehmet Kanbay may publish in the future.

Co-authorship network of co-authors of Mehmet Kanbay

This figure shows the co-authorship network connecting the top 25 collaborators of Mehmet Kanbay. A scholar is included among the top collaborators of Mehmet Kanbay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehmet Kanbay. Mehmet Kanbay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanbay, Mehmet, et al.. (2025). siRNA ‐based therapeutics for lipoprotein (a) lowering: A path toward precision cardiovascular medicine. European Journal of Clinical Investigation. 55(9). e70079–e70079. 1 indexed citations

Gürses, Bengı, Sidar Çöpür, Said İncir, et al.. (2025). Effects of plant-based diet on metabolic parameters, liver and kidney steatosis: a prospective interventional open-label study. British Journal Of Nutrition. 133(3). 289–298. 4 indexed citations

Voroneanu, Luminița, et al.. (2025). Advances in Multitarget Therapeutic Approaches for Immune-Mediated Glomerular Diseases. Life. 15(2). 243–243.

Kanbay, Mehmet, et al.. (2025). The Impact of Ultra‐Processed Food Consumption on Frailty and Sarcopenia: A Systematic Review. Journal of Human Nutrition and Dietetics. 38(4). e70096–e70096.

Kanbay, Mehmet, et al.. (2024). Ziltivekimab for anemia and atherosclerosis in chronic kidney disease: a new hope?. Journal of Nephrology. 38(2). 403–414.

Kanbay, Mehmet, et al.. (2024). Impact of weight change on kidney transplantation outcomes: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 27(3). 1369–1378.

Grigoraș, Ioana, Daniel Rusu, Raluca Ada Popa, et al.. (2024). Correlations between preoperative fluid status assessed by bioimpedance analysis and hypotension during anaesthesia induction. Anaesthesiology Intensive Therapy. 56(3). 177–184. 1 indexed citations

Kanbay, Mehmet, Sidar Çöpür, Abduzhappar Gaipov, et al.. (2024). An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management. Diabetes Obesity and Metabolism. 26(7). 2531–2545. 3 indexed citations

Sarafidis, Pantelis, Charles J. Ferro, Maria Eleni Alexandrou, et al.. (2023). Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA). Clinical Kidney Journal. 16(11). 1885–1907. 20 indexed citations

10.

Kanbay, Mehmet, et al.. (2023). Future treatments in hypertension: Can we meet the unmet needs of patients?. European Journal of Internal Medicine. 115. 18–28. 8 indexed citations

11.

Tanrıöver, Cem, et al.. (2023). Early aging and premature vascular aging in chronic kidney disease. Clinical Kidney Journal. 16(11). 1751–1765. 25 indexed citations

12.

Hahn, Kai, Bernardo Rodríguez‐Iturbe, Laura Gabriela Sánchez‐Lozada, et al.. (2022). Primary aldosteronism: A consequence of sugar and western Diet?. Medical Hypotheses. 160. 110796–110796. 3 indexed citations

13.

Kuwabara, Masanari, Mehmet Kanbay, Koichiro Niwa, et al.. (2020). Hyperosmolarity and Increased Serum Sodium Concentration Are Risks for Developing Hypertension Regardless of Salt Intake: A Five-Year Cohort Study in Japan. Nutrients. 12(5). 1422–1422. 18 indexed citations

14.

Dağel, Tuncay, Christopher R. King, Masanari Kuwabara, et al.. (2017). Dietary and commercialized fructose: Sweet or sour?. International Urology and Nephrology. 49(9). 1611–1620. 25 indexed citations

15.

Afşar, Barış, Mahmut İlker Yılmaz, Dimitrie Siriopol, et al.. (2016). Thyroid function and cardiovascular events in chronic kidney disease patients. Journal of Nephrology. 30(2). 235–242. 27 indexed citations

16.

Lueder, Thomas G. von, Nicolas Girerd, Dan Atar, et al.. (2015). Serum Uric Acid is Associated with Mortality and Heart Failure Hospitalizations in Patients with Complicated Myocardial Infarction: Findings from the High-Risk Myocardial Infarction Database Initiative. European Journal of Heart Failure. 17(11). 1144–1151. 80 indexed citations

17.

Uz, Ebru, Hacer Haltaş, Nüket Bavbek, et al.. (2011). Karyomegalic tubulointerstitial nephritis: A rare cause of chronic kidney disease. Nephro-Urology Monthly. 2011(3). 201–203. 5 indexed citations

18.

Türkay, Cansel, et al.. (2009). T-wave depletion and bradycardia possibly secondary to acute pancreatitis: Review of the literature. The Turkish Journal of Gastroenterology. 20(4). 295–297. 2 indexed citations

19.

Kanbay, Mehmet, Sema Karakuş, & Uğur Yılmaz. (2005). Portal Vein Thrombosis Due to Hyperhomocysteinemia Caused by Vitamin B-12 Deficiency. Digestive Diseases and Sciences. 50(12). 2362–2363. 6 indexed citations

20.

Kanbay, Mehmet, et al.. (2004). Hepatic lymphoma metastasis presenting with severe acute liver failure: a rare case.. PubMed. 15(2). 94–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact